Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403)
Anticancer Research · 2025
DOI: 10.21873/anticanres.17418 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Anticancer Research, 2025. Verfasst von Naotoshi Sugimoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan; na2-sugimoto@oici.jp. Hauptthemen laut MEDLINE: Stomach Neoplasms, Capecitabine, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan; na2-sugimoto@oici.jp.
- Department of Surgery, Kaizuka City Hospital, Kaizuka, Japan.
- Department of Surgery, Minoh City Hospital, Minoh, Japan.
- Department of Gastroenterological Surgery, Kitano Hospital, Osaka, Japan.
- Department of Surgery, Nagahama City Hospital, Nagahama, Japan.
- Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan.
Zitieren
APA
Sugimoto, N., Kawada, J., Oka, Y., Ueda, S., Murakami, K., Nishikawa, K., Kurokawa, Y., Fujitani, K., Kawakami, H., Endo, S., Sakai, D., Shimokawa, T., & Satoh, T. (2025). Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403). Anticancer Research. https://doi.org/10.21873/anticanres.17418
Vancouver
Sugimoto N, Kawada J, Oka Y, Ueda S, Murakami K, Nishikawa K, et al. Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403). Anticancer Research. 2025. doi:10.21873/anticanres.17418
BibTeX
@article{Sugimoto2025,
author = {Sugimoto, Naotoshi and Kawada, Junji and Oka, Yoshio and Ueda, Shugo and Murakami, Kohei and Nishikawa, Kazuhiro and Kurokawa, Yukinori and Fujitani, Kazumasa and Kawakami, Hisato and Endo, Shunji and Sakai, Daisuke and Shimokawa, Toshio and Satoh, Taroh},
title = {Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403)},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17418}
}
EUVIMED